Feature

Medicare Advantage enrollment up again in 2017


 

Enrollment in Medicare Advantage plans increased for the 13th consecutive year in 2017 and now represents one-third of all Medicare beneficiaries, according to the Kaiser Family Foundation.

Currently, 19 million beneficiaries are enrolled in Medicare Advantage, more than triple the number who were enrolled when the program hit its low point of 5.3 million (13% of all beneficiaries) in 2003 and 2004 and 71% higher since the Affordable Care Act was passed in 2010, Kaiser said in a recent report.

Total Medicare Advantage enrollment, 1999-2017
That growth is expected to continue. Congressional Budget Office projections suggest that Medicare Advantage enrollment will reach 41% of all beneficiaries by 2027, the Kaiser investigators said.

As growth continues, however, so does concentration among the private firms administering the plans. In 2017, UnitedHealthcare and Humana together account for 41% of enrollment in Medicare Advantage, “and, in 17 states, one company has more than half of all Medicare Advantage enrollment – an indicator that these markets may not be very competitive,” they noted.

Recommended Reading

Trump administration loosens up HealthCare.gov
MDedge Hematology and Oncology
President’s budget: Malpractice reform but deep health care cuts
MDedge Hematology and Oncology
Health reform action shifts to Senate, exacerbated by poor AHCA CBO score
MDedge Hematology and Oncology
The ‘monster note’ in EHR systems rarely helps
MDedge Hematology and Oncology
Public favors Obamacare over Trumpcare
MDedge Hematology and Oncology
As government-funded cancer research sags, scientists fear U.S. is ‘losing its edge’
MDedge Hematology and Oncology
Cost, value of new cancer treatments rarely correlate
MDedge Hematology and Oncology
Test goes wide and deep to detect free tumor DNA in blood
MDedge Hematology and Oncology
Travel restrictions bar surgeon from U.S. meeting
MDedge Hematology and Oncology
David Henry's JCSO podcast, May-June 2017
MDedge Hematology and Oncology